Condition
Adrenal Cortical Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Adrenal Cortical Carcinoma clinical trials that are recruiting, at sites in 4 countries (most in United States (2), China (2), Italy (1)). By phase: Phase 2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Adrenal Cortical Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Strasbourg cohort of people with adrenal cortical carcinoma | — | Strasbourg | Recruiting | Jan 13, 2026 |
| Cemiplimab maintenance for advanced adrenocortical carcinoma | Phase 2 | Brescia, Brescia | Recruiting | Jul 25, 2025 |
| Combining PD-1 inhibitor with Apatinib and Mitotane for advanced adrenal cancer treatment | Phase 2 | Chengdu, Sichuan | Recruiting | Feb 17, 2025 |
| Personalized mRNA vaccine for advanced endocrine tumors | — | Shanghai, Shanghai Municipality | Recruiting | Nov 21, 2023 |
| Cabozantinib plus pembrolizumab for advanced or unresectable adrenal cortical cancer | Phase 2 | Atlanta, Georgia and 1 other locations | Recruiting | Aug 23, 2023 |
| Combining PDS01ADC with targeted liver chemotherapy for certain cancers | Phase 2 | Bethesda, Maryland | Recruiting | Mar 18, 2022 |
All recruiting trials (6)
-
Strasbourg cohort of people with adrenal cortical carcinoma
This project collects clinical, imaging and pathology information from adults treated at Strasbourg University Hospital to better understand adrenal cortical carcinoma.
-
Cemiplimab maintenance for advanced adrenocortical carcinoma
This trial will test whether giving cemiplimab as maintenance immunotherapy after first-line EDP-M chemotherapy can delay progression in adults with advanced adrenocortical carcinoma who achieved a response or stable disease.
-
Combining PD-1 inhibitor with Apatinib and Mitotane for advanced adrenal cancer treatment
This study is testing a new combination of three medications to see if it can help people with advanced adrenal cancer who haven't had treatment yet.
-
Personalized mRNA vaccine for advanced endocrine tumors
This study is testing a personalized mRNA vaccine to see if it can help patients with advanced endocrine tumors who haven't had success with standard treatments.
-
Cabozantinib plus pembrolizumab for advanced or unresectable adrenal cortical cancer
This trial tests whether adding cabozantinib to pembrolizumab can shrink or control advanced, metastatic, or unresectable adrenal cortical cancer.
-
Combining PDS01ADC with targeted liver chemotherapy for certain cancers
This study is testing if a new cancer treatment that combines an immune booster with targeted liver chemotherapy can help people with certain advanced cancers feel better and live longer.
Related topics
Quick answers
How many Adrenal Cortical Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), China (2 trials), Italy (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.